The tissue engineering market in Europe is expected to grow from US$ 3,859.49 million in 2021 to US$ 8,520.70 million by 2028; it is estimated to grow at a CAGR of 12.0% from 2021 to 2028.
The rising incidence of chronic diseases and increasing number of trauma injuries and road accidents drive the demand for advanced treatment procedures, including tissue engineering. Road accidents are among the major fatalities worldwide as they cause serious injuries to bones and organs. As per the World Health Organization (WHO), ~20-50 million people get injured every year in road accidents. Tissue engineering offers alternatives to surgical reconstruction, transplantation, and mechanical device instruction to repair damaged tissues. The tissue engineering market is mainly driven by a continuous need for effective regenerative treatments to treat increasing cases of diabetes, obesity, and other disorders caused by lifestyle changes; surging population of elderly people; and rising number of trauma cases. A spinal cord injury (SCI) can cause damage to the spinal cord that temporarily or permanently changes its function. Globally, the mean prevalence of traumatic and nontraumatic SCI is estimated at 1:1000, and the annual incidence ranges from 2.1 to 130.7/million in developing countries and from 15 to 39/million in developed countries. According to Multidisciplinary Digital Publishing Institute (MDPI), an estimated 3 million people across the world suffer from traumatic SCI, and ~180,000 new cases are reported each year. SCI often results in devastating, long-lasting neurological deficits, manifesting as dysfunction of the motor, sensory, or autonomic nervous systems below the level of injury. To thoroughly repair or regenerate damaged tissues or organs and restore their functions are required. The advent of Tissue Engineering and Regenerative Medicine (TERM) seems to make this possible. Tissue engineering combines cells, scaffolds, and growth factors to regenerate tissue or replace damaged or diseased tissue. In contrast, regenerative medicine combines tissue engineering with other strategies, including cell-based therapy, gene therapy, and immunomodulation, to induce tissue/organ regeneration in vivo. Cancer is among the leading causes of mortality worldwide, and the disease affects a huge population. Therefore, it acts as a huge financial burden on society. According to the WHO, in 2018, ~9.6 million deaths occurred due to cancer globally. However, growing research on developing effective cancer treatments fuel the market growth. Gene therapy and cell therapy are transforming the cancer treatment landscape. For example, Novartis Kymriah is used in the treatment of diffuse large B-cell lymphoma. The rising number of launches of such products would be drive the demand for cell and gene therapies, which is expected to propel the tissue engineering market in the coming years.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe tissue engineering market at a substantial CAGR during the forecast period.
Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Organogenesis Inc.; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the Europe tissue engineering market.
The rising incidence of chronic diseases and increasing number of trauma injuries and road accidents drive the demand for advanced treatment procedures, including tissue engineering. Road accidents are among the major fatalities worldwide as they cause serious injuries to bones and organs. As per the World Health Organization (WHO), ~20-50 million people get injured every year in road accidents. Tissue engineering offers alternatives to surgical reconstruction, transplantation, and mechanical device instruction to repair damaged tissues. The tissue engineering market is mainly driven by a continuous need for effective regenerative treatments to treat increasing cases of diabetes, obesity, and other disorders caused by lifestyle changes; surging population of elderly people; and rising number of trauma cases. A spinal cord injury (SCI) can cause damage to the spinal cord that temporarily or permanently changes its function. Globally, the mean prevalence of traumatic and nontraumatic SCI is estimated at 1:1000, and the annual incidence ranges from 2.1 to 130.7/million in developing countries and from 15 to 39/million in developed countries. According to Multidisciplinary Digital Publishing Institute (MDPI), an estimated 3 million people across the world suffer from traumatic SCI, and ~180,000 new cases are reported each year. SCI often results in devastating, long-lasting neurological deficits, manifesting as dysfunction of the motor, sensory, or autonomic nervous systems below the level of injury. To thoroughly repair or regenerate damaged tissues or organs and restore their functions are required. The advent of Tissue Engineering and Regenerative Medicine (TERM) seems to make this possible. Tissue engineering combines cells, scaffolds, and growth factors to regenerate tissue or replace damaged or diseased tissue. In contrast, regenerative medicine combines tissue engineering with other strategies, including cell-based therapy, gene therapy, and immunomodulation, to induce tissue/organ regeneration in vivo. Cancer is among the leading causes of mortality worldwide, and the disease affects a huge population. Therefore, it acts as a huge financial burden on society. According to the WHO, in 2018, ~9.6 million deaths occurred due to cancer globally. However, growing research on developing effective cancer treatments fuel the market growth. Gene therapy and cell therapy are transforming the cancer treatment landscape. For example, Novartis Kymriah is used in the treatment of diffuse large B-cell lymphoma. The rising number of launches of such products would be drive the demand for cell and gene therapies, which is expected to propel the tissue engineering market in the coming years.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe tissue engineering market at a substantial CAGR during the forecast period.
Europe Tissue Engineering Market Segmentation
The Europe tissue engineering market is segmented on the basis of material type, application, and country. Based on material type, the market is segmented into biologically derived materials, synthetic materials, and others. In 2021, the biologically derived materials segment held a larger share of the market; and Synthetic Materials is expected to register a higher CAGR during the forecast period. Based on application, the market is categorised into orthopedic, musculoskeletal, & spine, skin & integumentary, cardiology and vascular, neurology, cancer, gi, gynecology, urology, and others. In 2021, the orthopedic, musculoskeletal, & spine segment held the largest market share; and skin & integumentary is expected to register the highest CAGR in the market during the forecast period. Based on country, the Europe tissue engineering market is segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. In 2021, Germany held the largest market share; and it is also expected to grow at the fastest CAGR during the forecast period.Zimmer Biomet; B. Braun Melsungen AG; Stryker Corporation; AbbVie, Inc.; Integra LifeSciences Holdings Corporation; Organogenesis Inc.; Medtronic; Baxter International Inc.; Johnson and Johnson Services, Inc.; 3M; and Cook Biotech Inc. are among the leading companies in the Europe tissue engineering market.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Tissue Engineering Market - By Material Type
1.3.2 Europe Tissue Engineering Market - By Application
1.3.3 Europe Tissue Engineering Market - By Country
2. Europe Tissue Engineering Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Tissue Engineering - Market Landscape
4.1 Overview
4.2 Europe
4.3 Expert Opinion
5. Europe Tissue Engineering Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Growing Number of Road Accidents and Trauma Injuries, and Elevating Incidence of Chronic Diseases
5.1.2 Strengthening Technological Advancements in the Field of 3D Tissue Engineering
5.2 Key Market Restraints
5.2.1 Expensive Cost of Treatment Options Involving Tissue Engineering
5.3 Key Market Opportunities
5.3.1 Raising Growth in the Healthcare Market Across the Region
5.4 Future Trends
5.4.1 Burgeoning Advancements in Regenerative Medicine
5.5 Impact Analysis
6. Europe Tissue Engineering Market Analysis
6.1 Europe Tissue Engineering Market Revenue Forecast and Analysis
7. Europe Tissue Engineering Market Analysis - By Material Type
7.1 Overview
7.2 Europe Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)
7.3 Synthetic Material
7.3.1 Overview
7.3.2 Synthetic Material: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Biologically Derived Materials
7.4.1 Overview
7.4.2 Biologically Derived Materials: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8. Europe Tissue Engineering Market - By Application
8.1 Overview
8.2 Europe Tissue Engineering Market, by Application, 2022 and 2028 (%)
8.3 Orthopedic, Musculoskeletal & Spine
8.3.1 Overview
8.3.2 Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Neurology
8.4.1 Overview
8.4.2 Neurology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Cardiology & Vascular
8.5.1 Overview
8.5.2 Cardiology & Vascular: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Skin & Integumentary
8.6.1 Overview
8.6.2 Skin & Integumentary: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Cancer
8.7.1 Overview
8.7.2 Cancer: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.8 GI & Gynaecology
8.8.1 Overview
8.8.2 GI & Gynaecology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.9 Urology
8.9.1 Overview
8.9.2 Urology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9. Europe Tissue Engineering Market - Country Analysis
9.1 Overview
9.1.1 Europe: Tissue Engineering Market, by Country, 2022 & 2028 (%)
9.1.1.1 Germany: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.1 Germany: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.2 Germany Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.1.1.3 Germany Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.1.2 UK: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3 UK: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.1 UK Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.1.3.2 UK Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.1.4 France: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.5 France: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.1 France Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.1.5.2 France Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.1.6 Spain: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.1 Spain: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.2 Spain Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.1.6.3 Spain Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.1.7 Italy: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.7.1 Italy: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.7.2 Italy Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.1.7.3 Italy Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.1.1.8 Rest of Europe: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.8.1 Rest of Europe: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
9.1.1.8.2 Rest of Europe Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
9.1.1.8.3 Rest of Europe Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
10. Europe Tissue Engineering Market - Industry Landscape
10.1 Organic Developments
10.1.1 Overview
10.2 Inorganic Developments
10.2.1 Overview
11. Company Profiles
11.1 Zimmer Biomet
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 B. Braun Melsungen AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Stryker Corporation
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 AbbVie, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Integra LifeSciences Holdings Corporation
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Organogenesis Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Medtronic
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Baxter International Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Johnson and Johnson Services, Inc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 3M
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Cook Biotech Inc.
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms
List of Figures
Figure 1. Europe Tissue Engineering Market Segmentation
Figure 2. Europe Tissue Engineering Segmentation - By Country
Figure 3. Europe Tissue Engineering Market Overview
Figure 4. The Biologically Derived Materials Segment Held Largest Share Of Material Type Segment In Tissue Engineering Market
Figure 5. Germany Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe Tissue Engineering Market, Industry Landscape
Figure 7. Europe PEST Analysis
Figure 8. Europe Tissue Engineering Market - Revenue Forecast and Analysis - 2020- 2028
Figure 9. Europe Tissue Engineering Market Revenue Share, by Material Type (2022 and 2028)
Figure 10. Synthetic Material: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Biologically Derived Materials: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Others: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Tissue Engineering Market, by Application, 2022 and 2028 (%)
Figure 14. Orthopedic, Musculoskeletal & Spine: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Neurology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Cardiology & Vascular: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Skin & Integumentary: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Cancer: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. GI & Gynecology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Urology: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe: Tissue Engineering Market, by Key Country - Revenue (2022) (US$ Million)
Figure 23. Europe: Tissue Engineering Market, by Country, 2022 & 2028 (%)
Figure 24. Germany: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. UK: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. France: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Spain: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Italy: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Rest of Europe: Tissue Engineering Market - Revenue and Forecast to 2028 (US$ Million)List of Tables
Table 1. Germany Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 3. United Kingdom Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
Table 4. United Kingdom Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5. France Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. France Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 7. Spain Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
Table 8. Spain Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 9. Italy Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of Europe Tissue Engineering Market, by Material Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of Europe Tissue Engineering Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic Developments Done By Companies
Table 15. Glossary of Terms, Europe Tissue Engineering market
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Zimmer Biomet
- B. Braun Melsungen AG
- Stryker Corporation
- AbbVie, Inc.
- Integra LifeSciences Holdings Corporation
- Organogenesis Inc.
- Medtronic
- Baxter International Inc.
- Johnson and Johnson Services, Inc.
- 3M
- Cook Biotech Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 133 |
| Published | August 2022 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 3859.49 Million |
| Forecasted Market Value ( USD | $ 8520.7 Million |
| Compound Annual Growth Rate | 12.0% |
| Regions Covered | Europe |
